Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis

BACKGROUND: We aimed to evaluate overall survival in US patients with amyotrophic lateral sclerosis (ALS) treated with intravenous (IV) edaravone compared with those not treated with IV edaravone in a real-world setting. METHODS: This exploratory retrospective comparative effectiveness observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Benjamin Rix, Berry, James D., Ciepielewska, Malgorzata, Liu, Ying, Zambrano, Gustavo Suarez, Zhang, Jeffrey, Hagan, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358426/
https://www.ncbi.nlm.nih.gov/pubmed/35958519
http://dx.doi.org/10.1016/j.eclinm.2022.101590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358426/
https://www.ncbi.nlm.nih.gov/pubmed/35958519
http://dx.doi.org/10.1016/j.eclinm.2022.101590

Ejemplares similares